MeSH Browser

MeSH Supplementary: levonadifloxacin
Unique ID: C000706771
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C000706771
Entry Term(s): (12S)-8-(4-((2S)-2-aminopropanoyl)oxypiperidin-1-yl)-7-fluoro-12-methyl-4-oxo-1-azatricyclo(7.3.1.05,13)trideca-2,5,7,9(13)-tetraene-3-carboxylic acid; (S)-(-)-nadifloxacin; EMROK; EMROK O; L-Alanine, 1-((5S)-2-carboxy-9-fluoro-6,7-dihydro-5-methyl-1-oxo-1H,5H-benzo(ij)quinolizin-8-yl)-4-piperidinyl ester; WCK 2349; alalevonadifloxacin
Pharm Action: beta-Lactamase Inhibitors
Registry Numbers: 8WHH66L098; 57B7E1D1TG
Related Numbers: 57B7E1D1TG
Previous Indexing: Quinolones (2020-2023)
Heading Mapped to: *Quinolizines; *Fluoroquinolones
Frequency: 9
Note: broad-spectrum anti-MRSA benzoquinolizine quinolone agent; alalevonadifloxacin is prodrug of levonadifloxacin
Source: Antimicrob Agents Chemother. 2018 Feb 23;62(3). pii: e02297-17; Drug Des Devel Ther. 2019 Dec 24;13:4351-4365.
Date of Entry: 2020/06/08
Revision Date: 2022/11/02

levonadifloxacin MeSH Supplementary Concept Data 2025